 |
 |
|
|
|
Mechanisms
After coming across the main groupings of
nutrients implicated in the inhibition of carcinogenesis,
here lay the cellular mechanisms involved in the process of
this interface between nutrition and cancer, in order to get
a more in-depth view of the matter.
|
Oxidative damage
- Cells are susceptible to DNA damage when exposed to environmental
factors, including mutagens, which can lead to tumourigenesis.
See a simplified overview in Figure
1.
Some of these substances that can damage DNA and cause cancer
are known as free radical (FR) producers. These are charged
or uncharged chemical species that have an unpaired electron
in their outermost orbit and are therefore highly reactive,
causing a chain of chemical reactions that damage cells.
With the purpose of impeding this event, the adequate defence
response is by the action of an antioxidant or by the binding
of two FR. Other factors also engaged in mutagenesis and
cancer development include reactive oxygen species (ROS
- which result from oxidative phosphorylation reactions)
and lipid radicals. Both these elements are by-products
of cellular metabolism and respiration.
- FR are produced as a result of mitochondrial respiration
but also by exogenous factors like drugs and environmental
factors. They affect the metabolism of basic nutrients,
which can cause changes in nucleic acids (DNA) and potentially
lead to mutagenesis and subsequently tumour growth.
- An imbalance between FR generation and neutralisation
occurs in certain pathological conditions and FR accumulate
either due to excess production or lack of antioxidant bodies.
This is when the administration of agents capable of counteracting
FR or restoring innate defences is crucial to avoid organ
dysfunction and tissue damage.
Antioxidants fight against carcinogenesis
- A key solution is the presence of antioxidants, which
are natural compounds found in aqueous and lipid parts of
the body. They inactivate and 'scavenge' such radicals,
and can be classified into:
- Intrinsic antioxidant enzymatic systems
(such as Gluthianone transferases and Catalases),
being the first line of protection against oxidative
damage and capable of antagonising the initiation of
carcinogenesis. They are known to decrease in concentration
with age, fact that could hypothetically be associated
with the late onset of degenerative and carcinogenic
diseases.
- Nonenzymatic antioxidants, encompassing
a wide selection of substances found in the human diet
(including vitamins A, C and E, carotenoids, glutathione
and selenium).
- FR can cause mutations, deletions, gene amplifications,
and rearrangements in the sequence of DNA, triggering the
activation of various proto-oncogenes and/or tumour suppressor
genes. Chemical and conformational changes in DNA, and specially
oxidative damage to specific points of polymerase (responsible
for the duplication of DNA), are common lesions which give
rise to mutations. It is thought that there is a temporal
relationship between oxidative stress, genomic instability
and the development of cancer. See Figure
2.
- Most of the alterations that are produced in the mitochondrial
genome can boost the generation of ROS because of altered
production of essential components (antioxidant enzymes).
This impairment contributes not only to the process of ageing,
but also to tumourigenesis. Nonetheless, FR are also used
beneficially in immune responses to destroy invading bacteria
and other pathogens.
- Antioxidants play a major role in the inactivation of
FR, by 'scavenging' them. Some prevent initiation of the
oxidation process, while others inhibit the cascade of oxidation
reactions. Free radicals are reduced by means of oxidation
of vitamins, which prevents lipid peroxidation in the cell
membrane. For a clearer idea on how these compounds act
upon the radicals, please see Figure
3.
|
|
|